Market Overview

Canaccord: Constellation Brands Investment A 'Transformational Event' For Canopy Growth

Share:
Canaccord: Constellation Brands Investment A 'Transformational Event' For Canopy Growth

Canopy Growth Corp (NYSE: CGC) announced Wednesday its beverage company partner Constellation Brands, Inc. (NYSE: STZ) is increasing its stake in the company to 38 percent. 

The Analyst

Canaccord Genuity's Matt Bottomley on Aug. 15 upgraded Canopy Growth from Hold to Speculative Buy and increased the price target for the company's Canadian stock (TSX:WEED) to C$50.

The Thesis

Constellation Brands will invest around $4 billion of capital in Canopy Growth, Bottomley said in the note. (See the analyst's track record here.)

The cannabis company plans to issue 140 million warrants that could result in further investment over the next three years that increases Constellation's stake to more than 50 percent, the analyst said.

Bottomley sees the investment as a "transformational event" for Canopy that allows the company to expand its platform. Canopy now has a dominant cash position in the Canadian cannabis industry, the analyst said.

"The company is substantially better suited to execute on a global first mover advantage with the capital and strategic leverage provided by Constellation."

Price Action

Canopy Growth was trading up 0.23 percent to $30.95 off the open Friday.

Related Links:

BofA Trims Constellation's Price Target, Sees Similar Investments From Beverage Companies On The Horizon

As Millennials Pivot From Booze To Buds, The Beer Industry Strikes Cannabis Partnerships

Latest Ratings for CGC

DateFirmActionFromTo
Sep 2018BenchmarkInitiates Coverage OnBuy
Aug 2018Canaccord GenuityUpgradesHoldSpeculative Buy

View More Analyst Ratings for CGC
View the Latest Analyst Ratings

Posted-In: Canaccord Genuity Matt BottomleyAnalyst Color Cannabis Upgrades Price Target Markets Analyst Ratings Best of Benzinga

 

Related Articles (STZ + CGC)

View Comments and Join the Discussion!

Tesla CEO Elon Musk: 'From A Personal Pain Standpoint, The Worst Is Yet To Come'

Oppenheimer Upgrades Nvidia: 'We See Continued Outsized Growth'